In another study, Empagliflozin, a sodium-glucose cotransporter 2 inhibitor that increases plasma ketone bodies60,61, was found to reduce aortic aneurysm diameter and aortic wall RANTES in Apoe−/− mice62. Here, CCL5 is linked to aortic aneurysm.